Surrey Heartlands

Joint Formulary & PAD

Intralipid - Severe systemic local anaesthetic toxicity

You are here : Home > Formulary Search > Intralipid - Severe systemic local anaesthetic toxicity

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Intravenous infusion
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Preferred

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Intralipid
Indication :
Severe systemic local anaesthetic toxicity
Group Name :
Keywords :
Lipid emulsion, cardiotoxicity
Brand Names Include :
Important Information :
https://www.toxbase.org/ . Intralipid 20%. Off-label use
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Intralipid is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Severe systemic local anaesthetic toxicity.

  • No records returned.

Committee Recommendations (1)

05 Feb 25 - ASPH DTC

The Surrey Heartlands Area Prescribing Committee agreed the traffic light status of this drug and indication as part of the Joint Formulary review.